首页> 外国专利> INACTIVATING PATHOGENS AND PRODUCING HIGHLY IMMUNOGENIC INACTIVATED VACCINES USING A DUAL OXIDATION PROCESS

INACTIVATING PATHOGENS AND PRODUCING HIGHLY IMMUNOGENIC INACTIVATED VACCINES USING A DUAL OXIDATION PROCESS

机译:使用双重氧化工艺灭活病原并产生高度免疫原性的灭活疫苗

摘要

Provided are surprisingly effective methods for inactivating pathogens, and for producing highly immunogenic vaccine compositions containing an inactivated pathogen rendered noninfectious by exposure to a Fenton reagent, or by exposure to a Fenton reagent or a component thereof in combination with a methisazone reagent selected from the group consisting of methisazone, methisazone analogs, functional group(s)/substructure(s) of methisazone, and combinations thereof. The methods efficiently inactivate pathogens, while substantially retaining pathogen antigenicity and/or immunogenicity, and are suitable for inactivating pathogens, or for the preparation of vaccines for a wide variety of pathogens with genomes comprising RNA or DNA, including viruses and bacteria. Also provided are highly immunogenic inactivated vaccine compositions prepared by using any of the disclosed methods, and methods for eliciting an immune response in a subject by administering such vaccine compositions.
机译:提供了令人惊奇地有效的方法,用于灭活病原体,以及生产高度免疫原性的疫苗组合物,该组合物包含通过暴露于芬顿试剂,或暴露于芬顿试剂或其组分与选自组的甲硝唑试剂组合而变得无感染力的灭活病原体。由甲虫zone,甲虫zone类似物,甲虫zone的官能团/亚结构及其组合组成。所述方法有效地灭活病原体,同时基本上保留病原体的抗原性和/或免疫原性,并且适用于灭活病原体,或适于制备具有包括RNA或DNA在内的包括病毒和细菌的基因组的多种病原体的疫苗。还提供了通过使用任何公开的方法制备的高度免疫原性的灭活疫苗组合物,以及通过施用此类疫苗组合物在受试者中引发免疫应答的方法。

著录项

  • 公开/公告号US2020108094A1

    专利类型

  • 公开/公告日2020-04-09

    原文格式PDF

  • 申请/专利权人 NAJÍT TECHNOLOGIES INC.;

    申请/专利号US201716300540

  • 发明设计人 IAN J. AMANNA;ELIZABETH A. POORE;

    申请日2017-05-10

  • 分类号A61K33/40;A61K39/112;A61K39/145;A61K39/02;A61K39/275;C12N7;

  • 国家 US

  • 入库时间 2022-08-21 11:19:31

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号